Author: mrr5831
-
Women in Medicine Conference Navigates a Virtual World
The third annual Northwestern Women in Medicine conference kicked off on December 17, and will feature monthly virtual lectures aimed to empower women in medicine to thrive in a virtual world.
-
Wellness Curriculum May Help Decrease Residency Burnout
A new wellness curriculum program developed by Northwestern Medicine faculty and residents may help decrease burnout among trainees, according to a recent study.
-
Improving Treatment for Triple-Negative Breast Cancer
A team led by Northwestern Medicine investigators has identified a novel molecular target that may improve the efficacy of current treatments for triple-negative breast cancer.
-
2020: A Year of Groundbreaking Discoveries During a Pandemic
Take a look back at a handful of groundbreaking research discoveries that marked one of, if not the most, unprecedented and transformative years for Feinberg.
-
PA Students Join ECMH Program
First-year students in the Physician Assistant (PA) Program have joined the Education-Centered Medical Home (ECMH) program for the first time, gaining early team-based clinical experiences and exposure.
-
Identifying Oncogenes through Epigenetic Markers
Northwestern Medicine investigators have discovered that oncogenes contain specific epigenetic markers called broad genic repression domains, which could help identify potential therapeutic targets for cancer treatment.
-
Novel “Gate Latch” Mechanism Essential for Activation of Immune System
Northwestern Medicine investigators have identified a novel “gate latch” mechanism within the Orai1 ion channel that is essential for proper activation of the immune system.
-
Mitochondria-Targeted Antioxidants Inhibit Tumor Growth
Northwestern Medicine investigators have discovered that inserting dietary antioxidants into the mitochondria of cancer cells may inhibit overall tumor growth.
-
Novel Drug May Remedy Antibiotic Resistant Infections
A novel antibiotic drug showed similar treatment effectiveness compared to current therapies in patients with antibiotic resistant bacterial infections, according to two complementary clinical trials.
-
Cheng Named AAAS Fellow
Shi-Yuan Cheng, PhD, professor in The Ken and Ruth Davee Department of Neurology in the Division of Neuro-oncology, has been named a fellow of the American Association for the Advancement of Science (AAAS) for his outstanding contributions to molecular and translational cancer research.
